150 related articles for article (PubMed ID: 20543187)
1. Cognitive decline precedes late-life longitudinal changes in vascular risk factors.
van Vliet P; Westendorp RG; van Heemst D; de Craen AJ; Oleksik AM
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):1028-32. PubMed ID: 20543187
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of traditional metabolic risk factors associate with specific causes of death in old age.
van Vliet P; Oleksik AM; van Heemst D; de Craen AJ; Westendorp RG
J Gerontol A Biol Sci Med Sci; 2010 May; 65(5):488-94. PubMed ID: 20154178
[TBL] [Abstract][Full Text] [Related]
3. The influence of vascular risk factors on cognitive decline in patients with Alzheimer's disease.
Blom K; Vaartjes I; Peters SA; Koek HL
Maturitas; 2014 Sep; 79(1):96-9. PubMed ID: 25059438
[TBL] [Abstract][Full Text] [Related]
4. Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.
Tortelli R; Lozupone M; Guerra V; Barulli MR; Imbimbo BP; Capozzo R; Grasso A; Tursi M; Di Dio C; Sardone R; Giannelli G; Seripa D; Misciagna G; Panza F; Logroscino G
J Alzheimers Dis; 2017; 59(1):121-130. PubMed ID: 28582862
[TBL] [Abstract][Full Text] [Related]
5. Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study.
Vuorinen M; Solomon A; Rovio S; Nieminen L; Kåreholt I; Tuomilehto J; Soininen H; Kivipelto M
Dement Geriatr Cogn Disord; 2011; 31(2):119-25. PubMed ID: 21273771
[TBL] [Abstract][Full Text] [Related]
6. Global Vascular Risk Score and CAIDE Dementia Risk Score Predict Cognitive Function in the Northern Manhattan Study.
Rundek T; Gardener H; Dias Saporta AS; Loewenstein DA; Duara R; Wright CB; Dong C; Levin B; Elkind MSV; Sacco RL
J Alzheimers Dis; 2020; 73(3):1221-1231. PubMed ID: 31884476
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure.
Scuteri A; Coluccia R; Castello L; Nevola E; Brancati AM; Volpe M
Eur Heart J; 2009 Jun; 30(12):1525-9. PubMed ID: 19406864
[TBL] [Abstract][Full Text] [Related]
8. Twenty-year trends in cardiovascular risk factors in India and influence of educational status.
Gupta R; Guptha S; Gupta VP; Agrawal A; Gaur K; Deedwania PC
Eur J Prev Cardiol; 2012 Dec; 19(6):1258-71. PubMed ID: 21947630
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial.
Peters R; Poulter R; Beckett N; Forette F; Fagard R; Potter J; Swift C; Anderson C; Fletcher A; Bulpitt CJ
J Hypertens; 2009 Oct; 27(10):2055-62. PubMed ID: 19696686
[TBL] [Abstract][Full Text] [Related]
10. Association between high-density lipoprotein and cognitive impairment in the oldest old.
van Exel E; de Craen AJ; Gussekloo J; Houx P; Bootsma-van der Wiel A; Macfarlane PW; Blauw GJ; Westendorp RG
Ann Neurol; 2002 Jun; 51(6):716-21. PubMed ID: 12112077
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the lipid profile in dementia and depression in the elderly.
Dimopoulos N; Piperi C; Salonicioti A; Psarra V; Mitsonis C; Liappas I; Lea RW; Kalofoutis A
J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):138-44. PubMed ID: 17712096
[TBL] [Abstract][Full Text] [Related]
12. Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors.
Raiko JR; Viikari JS; Ilmanen A; Hutri-Kähönen N; Taittonen L; Jokinen E; Pietikäinen M; Jula A; Loo BM; Marniemi J; Lehtimäki T; Kähönen M; Rönnemaa T; Raitakari OT; Juonala M
J Intern Med; 2010 Apr; 267(4):370-84. PubMed ID: 19754855
[TBL] [Abstract][Full Text] [Related]
13. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort.
Kanaya AM; Barrett-Connor E; Gildengorin G; Yaffe K
Arch Intern Med; 2004 Jun; 164(12):1327-33. PubMed ID: 15226167
[TBL] [Abstract][Full Text] [Related]
14. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs.
Mossello E; Pieraccioli M; Nesti N; Bulgaresi M; Lorenzi C; Caleri V; Tonon E; Cavallini MC; Baroncini C; Di Bari M; Baldasseroni S; Cantini C; Biagini CA; Marchionni N; Ungar A
JAMA Intern Med; 2015 Apr; 175(4):578-85. PubMed ID: 25730775
[TBL] [Abstract][Full Text] [Related]
15. [Isolated systolic hypertension and cognitive function in the aged. Experience of the Syst-Eur study].
Seux ML; Thijs L; Forette F
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1169-72. PubMed ID: 9404430
[TBL] [Abstract][Full Text] [Related]
16. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.
Solomon A; Kåreholt I; Ngandu T; Winblad B; Nissinen A; Tuomilehto J; Soininen H; Kivipelto M
Neurology; 2007 Mar; 68(10):751-6. PubMed ID: 17339582
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
18. Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan.
Chiang CJ; Yip PK; Wu SC; Lu CS; Liou CW; Liu HC; Liu CK; Chu CH; Hwang CS; Sung SF; Hsu YD; Chen CC; Liu SI; Yan SH; Fong CS; Chang SF; You SL; Chen CJ
Am J Geriatr Psychiatry; 2007 Sep; 15(9):762-71. PubMed ID: 17623813
[TBL] [Abstract][Full Text] [Related]
19. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.
Colao A; Pivonello R; Spiezia S; Faggiano A; Ferone D; Filippella M; Marzullo P; Cerbone G; Siciliani M; Lombardi G
J Clin Endocrinol Metab; 1999 Aug; 84(8):2664-72. PubMed ID: 10443657
[TBL] [Abstract][Full Text] [Related]
20. The role of metabolic syndrome factors on cognition using latent variable modeling: The neurocognitive study on aging.
Philippou E; Michaelides MP; Constantinidou F
J Clin Exp Neuropsychol; 2018 Dec; 40(10):1030-1043. PubMed ID: 29954250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
